Elsevier Introduces Protein Viewer, Bringing Science to Life

New Feature on SciVerse ScienceDirect Presents Proteins in Three Dimensions, Allowing Manipulation of Molecular Structures, to the Benefit of the Reader

AMSTERDAM, October 25, 2010 - Elsevier, a world-leading publisher of scientific, medical and technical
products and services, introduces Protein Viewer, a new, interactive feature
on SciVerse ScienceDirect for the Journal of Molecular Biology (JMB)
(www.sciencedirect.com/science/journal/00222836). With Protein Viewer,
readers of JMB now have the power to expand and rotate molecules within the
actual article. SciVerse ScienceDirect merges features of the World Protein
Database and Jmol, and embeds them into the article, making its use more
convenient and user-friendly.

"Protein Viewer will allow all readers to readily visualize and
manipulate molecular structures from within the article, without the need for
specialized stand-alone graphics software," said Peter Wright,
Editor-in-Chief of JMB. "Authors, too, will benefit from having this feature
front and center in their articles."

This interactive feature allows the reader to be more active in the
article, by allowing them to go more in-depth and be more focused on their
area of specific research. Protein Viewer allows the reader to choose the
display scheme, size, angle, colors, surface view, and more. Each individual
reader might be looking for a specific portion and presentation of the
molecule. Now, this individualization is at the fingertips of the reader.

"In our effort to improve the ease-of-use of research, it is apparent
that the research article and its related research data need to be integrated
in a user-friendly way," comments IJsbrand Jan Aalbersberg, VP Content
Innovation at Elsevier. "Our current SciVerse ScienceDirect platform enables
that very well, and after using this functionality in chemistry and earth
sciences earlier this year, Protein Viewer is the next step in exploiting
this feature for the life sciences community."

Protein Viewer is one of many innovative features from Elsevier and
SciVerse ScienceDirect, all designed to make the readers' experience
the most customized, useful, and relevant. Protein Viewer will be available
for more Elsevier journals, such as BBA Proteins and Proteomics and the
Journal of Structural Biology. More online innovations are planned for both
JMB and other Elsevier journals.

Please visit these links to explore this new feature:

dx.doi.org/10.1016/j.jmb.2010.05.054

dx.doi.org/10.1016/j.jmb.2010.06.019

About SciVerse ScienceDirect

Over a quarter of the world's full text scientific, technical and medical
(STM) peer-reviewed articles - managed by renowned editors, written by
respected authors and read by researchers from around the globe - are
available in one place: SciVerse ScienceDirect.

Elsevier's extensive and unique full-text collection covers authoritative
titles from the core scientific literature including high impact factor
titles such as The Lancet, Cell and Tetrahedron. Over ten million articles
are available online, including Articles in Press which offer online access
to recently accepted manuscripts. The critical mass of trusted information
available on SciVerse ScienceDirect is unsurpassed. Coverage includes over
2,500 journal titles published by Elsevier and dynamic linking to journals
from approximately 2,000 STM publishers through CrossRef. An expanding
program of online major reference works, handbooks, book series and over
4,400 eBooks in all fields of science seamlessly interlinks with primary
research referenced in journal articles.

About Journal of Molecular Biology

The Journal of Molecular Biology was founded in 1959 by Sir John Kendrew,
a Nobel Prize winning biochemist and crystallographer. The Journal of
Molecular Biology publishes original scientific research concerning studies
of organisms or their components at the molecular level. Published weekly,
the journal provides up-to-date and comprehensive coverage of all aspects of
molecular biology. Edwin Southern, inventor of the Southern Blot, published
the first description of nucleic acid blotting in the pages of JMB. For more
information please visit www.elsevier.com/locate/jmb

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell
(www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/home.url), Reaxys (https://www.reaxys.com/), MD
Consult (www.mdconsult.com/) and Nursing Consult
(www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com/) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com/), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Harald Boersma
    Senior Manager, Corporate Relations, Elsevier
    H.Boersma@elsevier.com
    +31-20-485-27-36

Media Contact: Harald Boersma, Senior Manager, Corporate Relations, Elsevier, H.Boersma at elsevier.com, +31-20-485-27-36